首页> 外文期刊>The Journal of Experomental Medicine >A Key Role for Cc Chemokine Receptor 4 in Lipopolysaccharide-Induced Endotoxic Shock
【24h】

A Key Role for Cc Chemokine Receptor 4 in Lipopolysaccharide-Induced Endotoxic Shock

机译:Cc趋化因子受体4在脂多糖诱导的内毒素休克中的关键作用

获取原文
           

摘要

CC chemokine receptor (CCR)4, a high affinity receptor for the CC chemokines thymus and activation-regulated chemokine (TARC) and macrophage-derived chemokine (MDC), is expressed in the thymus and spleen, and also by peripheral blood T cells, macrophages, platelets, and basophils. Recent studies have shown that CCR4 is the major chemokine receptor expressed by T helper type 2 (Th2) polarized cells. To study the in vivo role of CCR4, we have generated CCR4-deficient (CCR4?/?) mice by gene targeting. CCR4?/? mice developed normally. Splenocytes and thymocytes isolated from the CCR4?/? mice failed to respond to the CCR4 ligands TARC and MDC, as expected, but also surprisingly did not undergo chemotaxis in vitro in response to macrophage inflammatory protein (MIP)-1α. The CCR4 deletion had no effect on Th2 differentiation in vitro or in a Th2-dependent model of allergic airway inflammation. However, CCR4?/? mice exhibited significantly decreased mortality on administration of high or low dose bacterial lipopolysaccharide (LPS) compared with CCR4+/+ mice. After high dose LPS treatment, serum levels of tumor necrosis factor α, interleukin 1β, and MIP-1α were reduced in CCR4?/? mice, and decreased expression of MDC and MIP-2 mRNA was detected in peritoneal exudate cells. Analysis of peritoneal lavage cells from CCR4?/? mice by flow cytometry also revealed a significant decrease in the F4/80+ cell population. This may reflect a defect in the ability of the CCR4?/? macrophages to be retained in the peritoneal cavity. Taken together, our data reveal an unexpected role for CCR4 in the inflammatory response leading to LPS-induced lethality.
机译:CC趋化因子受体(CCR)4是CC趋化因子胸腺和活化调节趋化因子(TARC)和巨噬细胞衍生趋化因子(MDC)的高亲和力受体,在胸腺和脾脏以及外周血T细胞中表达,巨噬细胞,血小板和嗜碱性粒细胞。最近的研究表明,CCR4是T型辅助2型(Th2)极化细胞表达的主要趋化因子受体。为了研究CCR4的体内作用,我们已经通过基因靶向产生了CCR4缺陷型(CCR4α/β)小鼠。 CCR4?/?小鼠正常发育。从CCR4α/β分离的脾细胞和胸腺细胞。小鼠未能像预期的那样对CCR4配体TARC和MDC做出反应,但令人惊讶的是,它在体外并未对巨噬细胞炎性蛋白(MIP)-1α做出反应。 CCR4缺失在体外或在变应性气道炎症的Th2依赖模型中对Th2分化没有影响。但是,CCR4?/?与CCR4 + / +小鼠相比,高剂量或低剂量细菌脂多糖(LPS)给药后小鼠的死亡率显着降低。大剂量LPS​​治疗后,CCR4α/β的血清肿瘤坏死因子α,白介素1β和MIP-1α降低。小鼠,并在腹膜渗出细胞中检测到MDC和MIP-2 mRNA的表达降低。分析来自CCR4β/β的腹膜灌洗细胞通过流式细胞仪检测的小鼠也显示F4 / 80 +细胞数量显着减少。这可能反映出CCR4α/β能力的缺陷。巨噬细胞保留在腹膜腔内。两者合计,我们的数据显示CCR4在导致LPS致死的炎症反应中具有意想不到的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号